Ratchet Laboratories Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 03-01-2025
- Paid Up Capital ₹ 11.37 Cr
as on 03-01-2025
- Company Age 21 Year, 3 Days
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 58.22 Cr
as on 03-01-2025
- Revenue -71.55%
(FY 2016)
- Profit 81.85%
(FY 2016)
- Ebitda 94.73%
(FY 2016)
- Net Worth -30.65%
(FY 2016)
- Total Assets -12.84%
(FY 2016)
About Ratchet Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 11.37 Cr.
The company currently has active open charges totaling ₹58.22 Cr.
Sanjay Vasudev, Sanjay Rana, and Manoj Kumar serve as directors at the Company.
- CIN/LLPIN
U24239DL2004PLC124183
- Company No.
124183
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2004
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ratchet Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Kumar  | Managing Director | 20-Jan-2004 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Vasudev | Director | 25-Nov-2017 | Current |
| Sanjay Rana | Additional Director | 18-Mar-2015 | Current |
Financial Performance of Ratchet Laboratories.
Ratchet Laboratories Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 71.55% decrease. The company also saw a substantial improvement in profitability, with a 81.85% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ratchet Laboratories?
In 2016, Ratchet Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 28 Mar 2014 | ₹5.86 Cr | Open |
Canara Bank Creation Date: 28 Mar 2014 | ₹3.70 M | Open |
Canara Bank Creation Date: 28 Mar 2014 | ₹1.47 Cr | Open |
How Many Employees Work at Ratchet Laboratories?
Unlock and access historical data on people associated with Ratchet Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ratchet Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ratchet Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
